Association of interleukin-1β gene polymorphisms in the occurrence of gastric ulcer in Southern Odisha, India
DOI:
https://doi.org/10.15584/ejcem.2025.3.24Keywords:
gastric ulcer, gene polymorphism, interleukin-1β, non-steroid anti-inflammatory drugAbstract
Introduction and aim. The occurrence of gastric ulcer (GU) is influenced by many factors including interleukin 1β (IL-1β) gene polymorphisms. In this study, the association of GU with IL-1β gene polymorphisms was investigated in patients with gastric disorders.
Material and methods. The patients were categorized into two groups, group 1: patients with normal impression in the upper-GI-endoscopy (n=135); group 2: patients with GU (n=135). Three single nucleotide variants (SNVs) of IL-1β gene [rs16944 (–511 C/T), rs1143627 (–31 C/T) and rs1143634 (+3954 C/T)] were investigated by PCR-RFLP method.
Results. The association of IL-1β gene polymorphisms and occurrence of GU along with other factors (socio-demographic and habits) showed patients with smoking, alcohol intake and NSAID use was high in group 2. For SNVs and occurrence of GU, rs1143627 (–31 ‘TT’) genotype was significantly high in group 2 (21.48%) compared to group 1 (9.63%), while the other two genotypes were comparable. Further, there was no association of any genotypes with smoking, alcohol intake and NSAID use, except NSAID use with rs1143627 (–31 C/T) in group 1.
Conclusion. The findings revealed, the habits like smoking, alcohol intake and recurrent NSAID use may influence the occurrence of GU while, the IL-1β gene polymorphisms have minimal impact on the occurrence of GU.
Supporting Agencies
This study (Research proposal ID: MKCGMC/MRU/024/2019) was funded by Department of Health Research, Ministry of Health and Family Welfare, Government of India for the establishment of Multi-Disciplinary Research Unit (MRU) at Maharaja Krishna Chandra Gajapati (M.K.C.G.) Medical College, Berhampur, Odisha, India.Downloads
References
Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017;390: 613-624. doi: 10.1016/S0140-6736(16)32404-7
Lim YJ. Genetic susceptibility of gastroduodenal disease in ethnic and regional diversity. Gut Liver. 2014;8(6):575-576. doi: 10.5009/gnl14313
GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;385(9963):117-171. doi: 10.1016/S0140-6736(14)61682-2
Yuan S, Chen J, Ruan X, et al. Smoking, alcohol consumption, and 24 gastrointestinal diseases: Mendelian randomization analysis. Elife. 2023;12:e84051. doi: 10.7554/eLife.84051
Maqbul MS, Alzaki RS, Meeralam RS, et al. Prevalence of peptic ulcer disease and its associated factors in Jeddah Saudi Arabia. Gastroenterology & Endoscopy. 2025;3(2025):13-21. doi: 10.1016/j.gande.2024.09.001
Chang YT, Wu MS, Shun CT, Lin MT, Chang MC, Lin JT. Association of polymorphisms of interleukin-1 beta gene and Helicobacter pylori infection with the risk of gastric ulcer. Hepatogastroenterology. 2002;49(47):1474-1476.
Hartland S, Newton JL, Griffin SM, Donaldson PT. A functional polymorphism in the interleukin-1 receptor-1 gene is associated with increased risk of Helicobacter pylori infection but not with gastric cancer. Dig Dis Sci. 2004;49(9):1545-1550. doi: 10.1023/b:ddas.0000042262.14969.2d
Motamedi Rad N, Rezaeishahmirzadi M, Shakeri S, Abbaszadegan MR, Shekari M. Association of IL-1B+3954 and IL-1RN Polymorphisms in Chronic Gastritis and Peptic Ulcer. Iran J Public Health. 2018;47(9):1364-1370.
Martínez-Carrillo DN, Garza-González E, Betancourt-Linares R, et al. Association of IL1B -511C/-31T haplotype and Helicobacter pylori vacA genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol. 2010;10:126. doi: 10.1186/1471-230X-10-126
Ramis IB, Vianna JS, Halicki PC, et al. Relationship of interleukin-1B gene promoter region polymorphism with Helicobacter pylori infection and gastritis. J Infect Dev Ctries. 2015;9(10):1108-1116. doi: 10.3855/jidc.6123.
Farshad S, Rasouli M, Jamshidzadeh A, et al. IL-1ß (+3953 C/T) and IL-8 (-251 A/T) gene polymorphisms in H. pylori mediated gastric disorders. Iran J Immunol. 2010; 7(2):96-108.
Santos JC, Ladeira MS, Pedrazzoli J Jr, Ribeiro ML. Relationship of IL-1 and TNF-α polymorphisms with Helicobacter pylori in gastric diseases in a Brazilian population.
Braz J Med Biol Res. 2012;45(9):811-817. doi: 10.1590/s0100-879x2012007500099
Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimura H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology. 2002;123(1):92-105. doi: 10.1053/gast.2002.34156Erratum in: Gastroenterology 2002;123(3):957.
Manchanda PK, Bid HK, Mittal RD. Ethnicity greatly influences the interleukin-1 gene cluster(IL-1b promoter, exon-5 and IL-1Ra) polymorphisms: a pilot study of a north Indian population. Asian Pac J Cancer Prev. 2005; 6(4):541-546.
Anda RF, Williamson DF, Escobedo LG, Remington PL. Smoking and the risk of peptic ulcer disease among women in the United States. Arch Intern Med. 1990;150(7):1437-1441.
Li LF, Chan RL, Lu L, et al. Cigarette smoking and gastrointestinal diseases: the causal relationship and underlying molecular mechanisms (review). Int J Mol Med. 2014;34(2):372-380. doi: 10.3892/ijmm.2014.1786
Liu Y, Xiao Z, Ye K, Xu L, Zhang Y. Smoking, alcohol consumption, diabetes, body mass index, and peptic ulcer risk: A two-sample Mendelian randomization study. Front Genet. 2023;13:992080. doi: 10.3389/fgene.2022.992080
Wang S, Zhang T, Li D, Cao X. The global, regional and national burden of peptic ulcer disease attributable to smoking from 1990 to 2021: A population-based study. Prev Med Rep. 2025;51:103019. doi: 10.1016/j.pmedr.2025.103019
Barakat MH, Menon KN, Badawi AR. Cigarette Smoking and Duodenal Ulcer Healing. Digestion. 1984;29:85-90.
Laucirica I, García Iglesias P, Calvet X. Peptic ulcer. Med Clin (Barc). 2023;161(6):260-266. doi: 10.1016/j.medcli.2023.05.008
Kamada T, Satoh K, Itoh T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2020. J Gastroenterol. 2021;56(4):303-322. doi: 10.1007/s00535-021-01769-0
Tai FWD, McAlindon ME. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clin Med (Lond). 2021;21(2):131-134. doi: 10.7861/clinmed.2021-0039
Tresca AJ. NSAIDs and Peptic Ulcer Risk. 2023. https://www.verywellhealth.com/nsaids-and-peptic-ulcers-1941723. Accessed April 23, 2024.
Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JB, Serrano MT, Peña AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol. 2001;125(3):368-375. doi: 10.1046/j.1365-2249.2001.01593.x
Zabaleta J, Camargo MC, Piazuelo MB, et al. Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol. 2006;101(1):163-71. doi: 10.1111/j.1572-0241.2006.00387.x
Hnatyszyn A, Wielgus K, Kaczmarek-Rys M, et al. Interleukin-1 gene polymorphisms in chronic gastritis patients infected with Helicobacter pylori as risk factors of gastric cancer development. Arch Immunol Ther Exp (Warsz). 2013;61(6):503-512. doi: 10.1007/s00005-013-0245-y
Zeng ZR, Hu PJ, Hu S, et al. Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003;52(12):1684-1689. doi: 10.1136/gut.52.12.1684
Caleman Neto A, Rasmussen LT, de Labio RW, et al. Gene polymorphism of interleukin 1 and 8 in chronic gastritis patients infected with Helicobacter pylori. J Venom Anim Toxins Incl Trop Dis. 2014;20:17. doi:10.1186/1678-9199-20-17
Matsukura N, Yamada S, Kato S, et al. Genetic differences in interleukin-1 betapolymorphisms among four Asian populations: an analysis of the Asian paradox between H. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res. 2003;22(1):47-55.
Chang YW, Jang JY, Kim NH, et al. Interleukin-1B (IL-1B) polymorphisms and gastric mucosal levels of IL-1beta cytokine in Korean patients with gastric cancer. Int J Cancer. 2005;114(3):465-471. doi: 10.1002/ijc.20724
Erzin Y, Koksal V, Altun S, et al. Role of host interleukin 1beta gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in clinical outcomes in Helicobacter pylori-positive Turkish patients with dyspepsia. J Gastroenterol. 2008;43(9):705-710. doi: 10.1007/s00535-008-2220-7
El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature. 2001;412(6842):99. doi: 10.1038/35083631
Tu S, Bhagat G, Cui G, al. Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008;14(5):408-419. doi: 10.1016/j.ccr.2008.10.011 Erratum in: Cancer Cell. 2008;14(6):494. Erratum in: Cancer Cell. 2011;19(1):154.
Cho JH, Choi JS, Chun SW, Lee S, Han KJ, Kim HM. The IL-1B Genetic Polymorphism Is Associated with Aspirin-Induced PepticUlcers in a Korean Ethnic Group. Gut Liver. 2016;10(3):362-368. doi:10.5009/gnl15129
Shiotani A, Sakakibara T, Yamanaka Y, et al. The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J Gastroenterol 2009;44(7):717-725. doi: 10.1007/s00535-009-0068-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
